Identification on preventive mechanism of glucagon-like peptide-1 (GLP-1) agonist for atherosclerosis model
Atherosclerosis(2023)
Abstract
Background and Aims: The glucagon-like peptide-1 (GLP-1) agonist, a new class of diabetic medication, reduces progression of atherosclerosis lesions. However, mechanism for the protective effect has not been clearly identified. Therefore, we sought to investigate an anti-atherosclerotic and anti-inflammatory mechanism of GLP-1 in atherosclerosis model.
MoreTranslated text
Key words
agonist,glucagon-like
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined